10 November 2026

CESCR NGo annual meeting

Share this post

HRI attended the CESCR NGO annual meeting held on 9 November. This meeting is an opportunity for civil society to ask questions, propose suggestions, and discuss the Committee’s working methods and thematic work. This year, the session had four thematic areas for discussion: (1) care, comprehensive care systems, and the recognition of unpaid care work and its relationship with the enjoyment of ESC rights; (2) debt and fiscal justice, including human rights obligations in sovereign debt management, austerity measures, and fiscal space for ESC rights; (3) artificial intelligence and ESC rights, including its impacts on their enjoyment and the role of States and technology companies; and (4) extraterritorial obligations and private actors, with a focus on the regulation of business and human rights. HRI's intervention focused on harm reduction as essential healthcare and the need to protect community-led services. We also asked the Committee to keep drug policy high on their agenda, including by resuming their work on the General Comment on the impact of drug policy on economic, social and cultural rights.

Dear Chair, Secretariat, and distinguished members of the Committee

Thank you for this valuable opportunity.

I speak on behalf of Harm Reduction International, an international organisation that uses data and advocacy to promote drug policy reform. For many years, we have engaged with this Committee on the impact of punitive drug policies on economic, social and cultural rights.

Well-designed drug policies, grounded in evidence and human rights, can help shape robust and effective health care systems. But no healthcare system is complete without harm reduction, and no state can advance human rights while punishing and stigmatising people who use drugs instead of caring for them.

Harm reduction is essential healthcare. It includes needle and syringe programmes, opioid agonist therapy and overdose prevention, but also legal aid and housing, among others. Much of it is delivered by community-led and peer-led organisations. Yet in 2022 harm reduction in low- and middle-income countries received just 6 per cent of required funding, while far more is spent on drug law enforcement.

Despite the progress at the international level – including the HRC res 60/26 and the recent OHCHR report on women and girls, significant gaps remain as harm reduction still falls short of what people need, particularly in the case of people deprived of liberty.

Criminalisation and stigmatisation create barriers to healthcare, putting people who use drugs at risk of overdose deaths, HIV and other infectious diseases. These impacts are even more acute for women: 35% women in prison worldwide are held for drug offences, compared with 19 per cent of men, mostly for low-level offences. Meanwhile, fear of arrest, losing their children and discrimination keeps women who use drugs away from healthcare.

Community-led and peer-led services are the backbone of harm reduction. Built on lived experience and trust, they reach people that formal health systems often fail or drive away, connecting them to care without judgement. Yet, criminalisation, stigmatisation and fundings cuts are threatening their work and undermining access to care and human rights monitoring and advocacy,

This Committee’s work is critical to advance the rights of people who use drugs and are otherwise affected by drug policies. We urge the Committee to keep this topic high in their agenda in country review process, asking States about harm reduction, including in prisons, sustainable funding for community-led services, and support for women carers.

We also encourage the Committee to contribute its expertise on economic, social and cultural rights to the CND Independent Expert Panel’s work ahead of the 2029 drug policy review.

Finally, while we understand that the work on the General Comment on drug policy has been postponed, we urge members to maintain their commitment to this work and welcome clarification on the Committee’s plans and an indicative timeline for taking it forward.

Thank you.

Don't miss our events
and publications

Subscribe to our newsletter